OncoImmune’s SACCOVID demonstrates significant therapeutic efficacy in Covid-19 trial

This article was originally published here

The trial’s top-line data from 203 participants demonstrate that severe or critical Covid-19 patients treated with SACCOVID witnessed speedy recovery and a significant reduction in disease progression to

The post OncoImmune’s SACCOVID demonstrates significant therapeutic efficacy in Covid-19 trial appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply